ALKG1269A mutation as a potential mechanism of acquired resistance to crizotinib in an ALK-rearranged inflammatory myofibroblastic tumor.

Michels, Sebastian Y F; Scheel, Andreas H; Wündisch, Thomas; Heuckmann, Johannes M; Menon, Roopika; Puesken, Michael; Kobe, Carsten; Pasternack, Helen; Heydt, Carina; Scheffler, Matthias; Fischer, Rieke; Schultheis, Anne M; Merkelbach-Bruse, Sabine; Heukamp, Lukas; Büttner, Reinhard; Wolf, Jürgen

ALK^G1269A mutation as a potential mechanism of acquired resistance to crizotinib in an ALK-rearranged inflammatory myofibroblastic tumor.

Michels, Sebastian Y F; Scheel, Andreas H; Wündisch, Thomas; Heuckmann, Johannes M; Menon, Roopika; Puesken, Michael; Kobe, Carsten; Pasternack, Helen; Heydt, Carina; Scheffler, Matthias; Fischer, Rieke; Schultheis, Anne M; Merkelbach-Bruse, Sabine; Heukamp, Lukas; Büttner, Reinhard; Wolf, Jürgen.

Afiliação

Michels SYF; 1Lung Cancer Group Cologne, University Hospital of Cologne, Cologne, Germany.
Scheel AH; 2Department I of Internal Medicine, Center for Integrated Oncology, University Hospital of Cologne, Cologne, Germany.
Wündisch T; 1Lung Cancer Group Cologne, University Hospital of Cologne, Cologne, Germany.
Heuckmann JM; 3Institute of Pathology, Center for Integrated Oncology, University Hospital of Cologne, Cologne, Germany.
Menon R; 4Comprehensive Cancer Center Düsseldorf, University Hospital of Düsseldorf, Düsseldorf, Germany.
Puesken M; NEO New Oncology AG, Cologne, Germany.
Kobe C; NEO New Oncology AG, Cologne, Germany.
Pasternack H; 6Department of Radiology, Center for Integrated Oncology, University Hospital of Cologne, Cologne, Germany.
Heydt C; 7Department of Nuclear Medicine, Center for Integrated Oncology, University Hospital of Cologne, Cologne, Germany.
Scheffler M; 1Lung Cancer Group Cologne, University Hospital of Cologne, Cologne, Germany.
Fischer R; 3Institute of Pathology, Center for Integrated Oncology, University Hospital of Cologne, Cologne, Germany.
Schultheis AM; 1Lung Cancer Group Cologne, University Hospital of Cologne, Cologne, Germany.
Merkelbach-Bruse S; 3Institute of Pathology, Center for Integrated Oncology, University Hospital of Cologne, Cologne, Germany.
Heukamp L; 1Lung Cancer Group Cologne, University Hospital of Cologne, Cologne, Germany.
Büttner R; 2Department I of Internal Medicine, Center for Integrated Oncology, University Hospital of Cologne, Cologne, Germany.
Wolf J; 1Lung Cancer Group Cologne, University Hospital of Cologne, Cologne, Germany.

NPJ Precis Oncol ; 1(1): 4, 2017.

Article em En | MEDLINE | ID: mdl-29872693

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: NPJ Precis Oncol Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: NPJ Precis Oncol Ano de publicação: 2017 Tipo de documento: Article